Literature DB >> 10377144

Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei.

P Santanirand1, V S Harley, D A Dance, B S Drasar, G J Bancroft.   

Abstract

Burkholderia pseudomallei, the causative agent of melioidosis, is a gram-negative bacterium capable of causing either acute lethal sepsis or chronic but eventually fatal disease in infected individuals. However, despite the clinical importance of this infection in areas where it is endemic, there is essentially no information on the mechanisms of protective immunity to the bacterium. We describe here a murine model of either acute or chronic infection with B. pseudomallei in Taylor Outbred (TO) mice which mimics many features of the human pathology. Intraperitoneal infection of TO mice at doses of >10(6) CFU resulted in acute septic shock and death within 2 days. In contrast, at lower doses mice were able to clear the inoculum from the liver and spleen over a 3- to 4-week period, but persistence of the organism at other sites resulted in a chronic infection of between 2 and 16 months duration which was eventually lethal in all of the animals tested. Resistance to acute infection with B. pseudomallei was absolutely dependent upon the production of gamma interferon (IFN-gamma) in vivo. Administration of neutralizing monoclonal antibody against IFN-gamma lowered the 50% lethal dose from >5 x 10(5) to ca. 2 CFU and was associated with 8,500- and 4,400-fold increases in the bacterial burdens in the liver and spleen, respectively, together with extensive destruction of lymphoid architecture in the latter organ within 48 h. Neutralization of either tumor necrosis factor alpha or interleukin-12 but not granulocyte-macrophage colony-stimulating factor, also increased susceptibility to infection in vivo. Together, these results provide the first evidence of a host protective mechanism against B. pseudomallei. The rapid production of IFN-gamma within the first day of infection determines whether the infection proceeds to an acute lethal outcome or becomes chronic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377144      PMCID: PMC116549          DOI: 10.1128/IAI.67.7.3593-3600.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Chronic or latent melioidosis.

Authors:  C W Kingston
Journal:  Med J Aust       Date:  1971-09-18       Impact factor: 7.738

2.  Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture.

Authors:  V S Harley; D A Dance; B S Drasar; G Tovey
Journal:  Microbios       Date:  1998

Review 3.  Immunity to intracellular microbial pathogens.

Authors:  S H Kaufmann
Journal:  Immunol Today       Date:  1995-07

Review 4.  The role of natural killer cells in host-parasite interactions.

Authors:  P Scott; G Trinchieri
Journal:  Curr Opin Immunol       Date:  1995-02       Impact factor: 7.486

5.  Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens.

Authors:  G Lertmemongkolchai; G Cai; C A Hunter; G J Bancroft
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

6.  Early gamma interferon production by natural killer cells is important in defense against murine listeriosis.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

7.  Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes.

Authors:  A M Egan; D L Gordon
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

8.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Tumor necrosis factor in septicemic melioidosis.

Authors:  Y Suputtamongkol; D Kwiatkowski; D A Dance; W Chaowagul; N J White
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

10.  Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection.

Authors:  J S Friedland; Y Suputtamongkol; D G Remick; W Chaowagul; R M Strieter; S L Kunkel; N J White; G E Griffin
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

View more
  89 in total

1.  Gamma interferon supplementation for melioidosis.

Authors:  Gavin C K W Koh; Direk Limmathurotsakul
Journal:  Antimicrob Agents Chemother       Date:  2010-10       Impact factor: 5.191

2.  Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.

Authors:  Gareth D Healey; Stephen J Elvin; Margaret Morton; E Diane Williamson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Authors:  Karen K Chu; Patcharaporn Tippayawat; Nicola J Walker; Sarah V Harding; Helen S Atkins; Bernard Maillere; Gregory J Bancroft; Ganjana Lertmemongkolchai; Daniel M Altmann
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

4.  Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Authors:  Patcharaporn Tippayawat; Maneerat Pinsiri; Darawan Rinchai; Donporn Riyapa; Amornrat Romphruk; Yunn-Hwen Gan; Raymond L Houghton; Philip L Felgner; Richard W Titball; Mark P Stevens; Edouard E Galyov; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

Review 5.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

6.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

7.  Caspase-1 mediates resistance in murine melioidosis.

Authors:  Katrin Breitbach; Guang Wen Sun; Jens Köhler; Kristin Eske; Patimaporn Wongprompitak; Gladys Tan; Yichun Liu; Yunn-Hwen Gan; Ivo Steinmetz
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

8.  Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  P Utaisincharoen; N Anuntagool; S Arjcharoen; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 9.  Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Sara K Bondi; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

10.  Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).

Authors:  Gerritje J W van der Windt; W Joost Wiersinga; Catharina W Wieland; Ivo C S I Tjia; Nicholas P Day; Sharon J Peacock; Sandrine Florquin; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.